Incidence of acute Charcot foot in patients with diabetes.

IF 1 4区医学 Q3 MEDICINE, GENERAL & INTERNAL

Danish medical journal Pub Date : 2025-03-25 DOI:10.61409/A08240556

Osman Heider Ahmed, Matilde Winther-Jensen, Ole Lander Svendsen

{"title":"Incidence of acute Charcot foot in patients with diabetes.","authors":"Osman Heider Ahmed, Matilde Winther-Jensen, Ole Lander Svendsen","doi":"10.61409/A08240556","DOIUrl":null,"url":null,"abstract":"Introduction: Acute Charcot foot is a rare but serious complication of diabetes mellitus. With improved diabetes treatment, the annual incidence of acute Charcot foot may have decreased. This study aimed to investigate the annual incidence and incidence rate of acute Charcot foot in patients with an ICD diagnosis code of diabetes in Denmark from 2000 to 2021. Furthermore, the analyses included differences between the five Danish regions. Finally, the impact of the COVID-19 pandemic and the nurses' strike in the summer of 2021 in Denmark was also examined.Methods: This was a register-based study conducted in Denmark from 2000 to 2021. Nation-wide and regional, annual incidence and incidence rates of acute Charcot foot were calculated. Kendall's tau was used to test changes in incidence rates.Results: A significant increase was found in the annual incidence of acute Charcot foot with a correlation of 0.6 (p less-than 0.0005) together with a decline in the annual incidence rate of acute Charcot foot (correlation of -0.6 with p = 0.0005). No differences were observed between theDanish regions. No change in acute Charcot foot incidence rate among diabetes patients was found during 2018-2021 (correlation of 0.3; p = 0.5).Conclusion: The annual incidence increased, whereas the annual incidence rate of acute Charcot foot in patients with an ICD diagnosis code of diabetes in Denmark declined during 2000-2021, with no significant regional differences or change during the COVID-19 and nurses' strike.Funding: None.Trial registration: Not relevant.","PeriodicalId":11119,"journal":{"name":"Danish medical journal","volume":"72 4","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Danish medical journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.61409/A08240556","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Acute Charcot foot is a rare but serious complication of diabetes mellitus. With improved diabetes treatment, the annual incidence of acute Charcot foot may have decreased. This study aimed to investigate the annual incidence and incidence rate of acute Charcot foot in patients with an ICD diagnosis code of diabetes in Denmark from 2000 to 2021. Furthermore, the analyses included differences between the five Danish regions. Finally, the impact of the COVID-19 pandemic and the nurses' strike in the summer of 2021 in Denmark was also examined.

Methods: This was a register-based study conducted in Denmark from 2000 to 2021. Nation-wide and regional, annual incidence and incidence rates of acute Charcot foot were calculated. Kendall's tau was used to test changes in incidence rates.

Results: A significant increase was found in the annual incidence of acute Charcot foot with a correlation of 0.6 (p less-than 0.0005) together with a decline in the annual incidence rate of acute Charcot foot (correlation of -0.6 with p = 0.0005). No differences were observed between theDanish regions. No change in acute Charcot foot incidence rate among diabetes patients was found during 2018-2021 (correlation of 0.3; p = 0.5).

Conclusion: The annual incidence increased, whereas the annual incidence rate of acute Charcot foot in patients with an ICD diagnosis code of diabetes in Denmark declined during 2000-2021, with no significant regional differences or change during the COVID-19 and nurses' strike.

Funding: None.

Trial registration: Not relevant.

查看原文本刊更多论文

糖尿病患者急性夏足的发生率。

急性夏足是糖尿病的一种罕见但严重的并发症。随着糖尿病治疗的改善，急性夏科足的年发病率可能已经下降。本研究旨在调查2000 - 2021年丹麦ICD诊断为糖尿病的患者中急性Charcot足的年发病率和发病率。此外，分析还包括丹麦五个地区之间的差异。最后，还研究了2019冠状病毒病大流行和2021年夏天丹麦护士罢工的影响。方法：这是一项基于登记的研究，于2000年至2021年在丹麦进行。计算全国和地区急性夏足的年发病率和发病率。Kendall的tau被用来测试发病率的变化。结果：急性Charcot足的年发病率明显升高，相关性为0.6 (p < 0.0005)，急性Charcot足的年发病率明显下降（相关性为-0.6,p = 0.0005）。丹麦地区之间没有观察到差异。2018-2021年糖尿病患者急性夏科足发病率无变化(相关系数为0.3；P = 0.5)。结论：2000-2021年丹麦糖尿病ICD诊断码患者急性夏科足的年发病率呈上升趋势，而年发病率呈下降趋势，在2019冠状病毒病和护士罢工期间无明显地区差异和变化。资金:没有。试验注册：不相关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Danish medical journal MEDICINE, GENERAL & INTERNAL-

CiteScore

2.30

自引率

6.20%

发文量

审稿时长

3-8 weeks

期刊介绍： The Danish Medical Journal (DMJ) is a general medical journal. The journal publish original research in English – conducted in or in relation to the Danish health-care system. When writing for the Danish Medical Journal please remember target audience which is the general reader. This means that the research area should be relevant to many readers and the paper should be presented in a way that most readers will understand the content. DMJ will publish the following articles: • Original articles • Protocol articles from large randomized clinical trials • Systematic reviews and meta-analyses • PhD theses from Danish faculties of health sciences • DMSc theses from Danish faculties of health sciences.